Fierce Pharma
AUGUST 5, 2024
While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market. | While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market.
MedCity News
AUGUST 5, 2024
Bayer reported a Phase 3 test of Kerendia in heart failure led to statistically significant reductions in cardiovascular death and hospitalizations. Detailed results will be presented during the European Society of Cardiology annual meeting in September. The post Bayer Looks to Expand Kerendia’s Label to Heart Failure After Phase 3 Win appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
AUGUST 5, 2024
The family of a Baltimore woman whose cells were extracted for medical research without her consent more than 70 years ago has filed another lawsuit against drugmakers that allegedly profited from | The family of a Baltimore woman whose cells were extracted for medical research without her consent more than 70 years ago has filed another lawsuit against drugmakers that allegedly profited from the discoveries they made using her genetic material.
MedCity News
AUGUST 5, 2024
During a webinar hosted by PitchBook, healthcare experts shared that the food-as-medicine space will likely see consolidation in the future, as well as advancements in technology and reimbursement. The post What Does the Future of the Food-As-Medicine Market Look Like? appeared first on MedCity News.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Fierce Pharma
AUGUST 5, 2024
Bristol Myers Squibb, while working its way through a major restructuring, has unveiled another round of layoffs in New Jersey. | Bristol Myers Squibb, while working its way through a major restructuring, has unveiled another round of layoffs in its home state of New Jersey.
MedCity News
AUGUST 5, 2024
With more SNFs being penalized and an increasing number of patients being referred to home health care, participating in an ACO may be a strategic solution to improving care coordination, organizational goals, and patient outcomes overall. The post How Data and Technology Are Strengthening the Relationships Between Accountable Care Organizations and Skilled Nursing Facilities appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
AUGUST 5, 2024
While burnout levels may be improving slightly, physicians’ administrative burden still remains a major issue. Providers are hungry for more tools designed to simplify these tasks, namely documentation, a new report shows. The post Most Physicians Are Excited About Clinical Documentation AI, Report Shows appeared first on MedCity News.
Fierce Pharma
AUGUST 5, 2024
Following a launch last summer, Krystal Biotech’s topical gene therapy Vyjuvek is continuing to make waves in the dystrophic epidermolysis bullosa (DEB) disease space. | The quarter marks a “transition point” in Vyjuvek’s launch, analysts at Evercore ISI wrote in a note to clients. While the analysts expect the drug's sales to keep growing, they cautioned of a potential slowdown in the third quarter and beyond as Krystal's initial commercial efforts shift to patient identification effo
MedCity News
AUGUST 5, 2024
The integration of AI holds the promise of catalyzing innovation and spearheading a healthcare reinvention. MedTech companies that can successfully integrate these technologies into their operations are poised not only to thrive but also to lead the transformation of healthcare delivery. The post Unlocking Value in Preventative Care: How MedTech Companies are Shifting Focus appeared first on MedCity News.
Fierce Pharma
AUGUST 5, 2024
The pharmaceutical industry is in a constant state of evolution, driven by technological advancements, shifting consumer behaviors, and a complex regulatory landscape. | Join us at Digital Pharma East 2024 on Sept. 9-12 in Philadelphia to learn, connect, and innovate with your life sciences marketing industry peers.
Pharmaceutical Technology
AUGUST 5, 2024
The European Commission (EC) has granted orphan drug designation (ODD) for Amylyx Pharmaceuticals’ AMX0035 to treat Wolfram syndrome.
pharmaphorum
AUGUST 5, 2024
uniQure sheds two-thirds of its staff as it refocuses around a leaner pipeline headed by Huntington's therapy AMT-130
PharmaTimes
AUGUST 5, 2024
Bowel cancer, the third most common cancer type worldwide, is the second most common cause of cancer death
pharmaphorum
AUGUST 5, 2024
At the start of this year, Bayer said there were two important trial readouts for the company to deliver near-term growth this year as it rebuilds its pipeline – and both have now delivered positive results in the space of a month.This morning, the German group revealed that mineralocorticoid receptor antagonist (MRA) Kerendia (finerenone) was able to reduce cardiovascular death and other heart failure events compared to placebo in the FINEARTS-HF trial.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
PharmaTimes
AUGUST 5, 2024
Head and neck cancer is currently recognised as the sixth most common cancer globally
pharmaphorum
AUGUST 5, 2024
A proposal by 23andMe founder and chief executive Anne Wojcicki to take the genetic testing company private has been rejected by a special committee of the board of directors.Wojcicki offered to buy all the shares in the company she does not already own last week for $0.40 apiece in cash, according to a Securities & Exchange Commission (SEC) filing, which indicated she and her associates own around 20% of the stock.
European Pharmaceutical Review
AUGUST 5, 2024
Sanofi is planning to construct a new insulin production facility at its BioCampus in Frankfurt Höchst, Germany. The investment will total approximately €1.3 billion by 2029, with the new facility set to secure the long-term supply of insulin for diabetic patients and “strengthen European security of supply”, the company added. Sanofi emphasised their commitment to production of this treatment as “as one of the world’s largest manufacturers of insulin”.
Pharmaceutical Commerce
AUGUST 5, 2024
In the final portion of his Pharma Commerce video interview, Dan Gagnon, UPS Healthcare’s VP of Global Strategy & Acquisition Integration, discusses the value in needle-to-needle and precision logistics, including its impact over the course of the next five years.
PharmExec
AUGUST 5, 2024
Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts, alternative solutions to ensure continued access to medications for all Americans, potential long term consequences if these pharmacy closures continue, and more
Pharmacy Times
AUGUST 5, 2024
Small adjustments in human pluripotent stem cell cultures and the molecule concentration patterns in the initial 5 days of differentiation are essential to “rescue” the lines.
PharmExec
AUGUST 5, 2024
Velys recently received 510(k) clearance from the FDA for planning and instrumenting spinal fusion procedures across the cervical, thoracolumbar, and sacroiliac spine.
Pharmaceutical Technology
AUGUST 5, 2024
Reinforced with additional data, Zevra’s arimoclomol data package has gained a positive opinion in Niemann-Pick disease type C from an FDA advisory committee.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PharmExec
AUGUST 5, 2024
Expanded indication makes Fibryga the first and only on-demand, virus-inactivated, human plasma-derived fibrinogen concentrate approved for this indication.
PharmaTech
AUGUST 5, 2024
Contract organizations offer sponsors specialized equipment, capacity, and expertise for testing, manufacturing, and packaging bio/pharmaceutical products.
PharmExec
AUGUST 5, 2024
The acquisition of Ypsomed’s pen needles and blood glucose monitoring system is expected to increase MTD’s production capacity to over 2.5 billion units.
PharmaVoice
AUGUST 5, 2024
Wilson, who founded UPenn’s gene therapy program three decades ago, will step down to start two new spinouts, Gemma Bio and Franklin Biolabs.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmacy Times
AUGUST 5, 2024
A pharmacy's relationship with its state board(s) of pharmacy is crucial for its operation and success, yet it is often overlooked due to the complex demands on pharmacists and pharmacy owners.
PharmaTech
AUGUST 5, 2024
Synovial sarcoma is a rare form of cancer impacting about 1000 adults in the United States each year, most of them men in their 30s or younger.
PharmExec
AUGUST 5, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
pharmaphorum
AUGUST 5, 2024
MSD and Daiichi Sankyo take anti-B7-H3 ADC ifinatamab deruxtecan (I-DXd) into phase 3 trial in small cell lung cancer
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Expert insights. Personalized for you.
359 
Let's personalize your content